We are Elixia.

As pharma’s trusted partner for patient recruitment and clinical trials management and analysis, Elixia is committed to improving the speed and efficiency of clinical trials to fuel medical breakthroughs. We envision a world where we help improve lives by making new treatments for complex diseases accessible to all communities much faster.

Rather than a CRO (clinical research organization), we call ourselves a CSO: a clinical site organization. Elixia’s deep understanding of site operations and our breakthrough approach to site management aim to reshape the traditional clinical trials landscape.


“Over the last 50 years, the lack of innovation and poor execution in the clinical trials industry is what’s caused the market to be characterized as inefficient and often ineffective. With a more tailored approach, we can transform the way clinical trials showcase success across the world and ultimately help to perpetuate faster regulatory approval for new molecules that have the ability to save patient lives and improve quality of life everywhere.”


Neal Patel


Our values


Patient Centricity & Accessibility

A company-wide commitment to ensuring inclusive representation and accessible clinical trials amongst diverse populations for all the therapeutic areas that we serve.


Novel treatments require novelty in mindset and we thrive on doing things differently. We approach each problem with curiosity and a fresh perspective. Problem-solving fuels us.

Multi-Disciplinary Collaboration

The breadth and depth of our team’s cross-disciplinary medical and scientific expertise allow us to better drive health outcomes and value in clinical trials through the power of our collaborative culture.


We are a relentless team, flexible in our approach, and passionately committed to the pursuit of reinventing the way clinical trials are conducted.

Commitment to Data Quality & Efficiency

Built for cross-team coordination and decision making, our operational workflows allow us to move with speed and efficiency without compromising precision and accuracy.

Team Excellence

Experienced in various medical and scientific arenas, our team is seasoned and passionate about propelling medicine forward. We never stray from our mission.

Our executive team

Neal A. Patel

Chief Executive Officer

Under his leadership, Elixia’s total enterprise value has more than quadrupled, the number of employees tripled and the company has received numerous accolades for its work across several therapeutic focuses.

Jim F. Crissy

Chief Operating Officer

In his role of COO for Elixia, Jim provides strategic direction and operational oversight to a diverse and unique system of logistics that reflects the disruptive nature of Elixia’s forward approach to clinical trials.

Sam Searcy

Chief Commercial Officer

Sam is an industry veteran who brings access to a professional network of the top CROs and pharma companies. Elixia’s disruptive model is fueled by his expertise in aligning therapeutic knowledge to client needs.

Harry Alcorn

Chief Scientific Officer

Harry masterfully orchestrates the fusion of operational strategy and scientific innovation with deep-rooted industry expertise. His command of our Early Phase Clinical Trials Division underpins Elixia’s leadership in niche-focused clinical trials.

Jennifer L. Yevoli

General Counsel

As General Counsel, Jennifer advises Elixia on a wide range of corporate, regulatory, contracting, and business issues and heads compliance and corporate integrity efforts across the organization.

See All Leadership